{
    "Trade/Device Name(s)": [
        "ACL TOP Family 50 Series",
        "ACL TOP 750",
        "ACL TOP 750 CTS",
        "ACL TOP 750 LAS",
        "ACL TOP 550 CTS",
        "ACL TOP 350 CTS"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K242127",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150877"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GKP"
    ],
    "Summary Letter Date": "July 18, 2024",
    "Summary Letter Received Date": "July 19, 2024",
    "Submission Date": "July 15, 2024",
    "Regulation Number(s)": [
        "21 CFR 864.5400"
    ],
    "Regulation Name(s)": [
        "Coagulation instrument"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family 50 Series",
        "ACL TOP 750",
        "ACL TOP 750 CTS",
        "ACL TOP 750 LAS",
        "ACL TOP 550 CTS",
        "ACL TOP 350 CTS"
    ],
    "Method(s)/Technology(ies)": [
        "Coagulometric (Turbidimetric) measurement",
        "Chromogenic (Absorbance) measurement",
        "Immunological measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ACL TOP Family 50 Series automated coagulation analyzers with added permission-based remote-control and software update features.",
    "Indications for Use Summary": "Bench top, fully automated, random access analyzers for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis.",
    "fda_folder": "Hematology"
}